NCT00352313View on ClinicalTrials.gov

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2008

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

ATN-161

Given IV

DRUG

carboplatin

Given IV

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00352313 - ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma | Biotech Hunter | Biotech Hunter